$2.48T
Total marketcap
$65.7B
Total volume
BTC 50.31%     ETH 15.99%
Dominance

Diamond Biotechnology Co., Ltd 6815.TWO Stock

104.5 TWD {{ price }} -1.415094% {{change_pct}}%
COUNTRY
Taiwan
Market Cap
2.87B TWD
LOW - HIGH [24H]
103 - 106.5 TWD
VOLUME [24H]
118.97K TWD
{{ volume }}
P/E Ratio
66.56
Earnings per share
1.57 TWD

Diamond Biotechnology Co., Ltd Price Chart

Diamond Biotechnology Co., Ltd 6815.TWO Financial and Trading Overview

Diamond Biotechnology Co., Ltd stock price 104.5 TWD
Previous Close 88.9 TWD
Open 85.5 TWD
Bid 88 TWD x N/A
Ask 89.2 TWD x N/A
Day's Range 85.5 - 89.4 TWD
52 Week Range 29.39 - 150.57 TWD
Volume 12.69K TWD
Avg. Volume 220.42K TWD
Market Cap 2.42B TWD
Beta (5Y Monthly) 0.322341
PE Ratio (TTM) 56.41026
EPS (TTM) 1.57 TWD
Forward Dividend & Yield 0.12 (0.13%)
Ex-Dividend Date August 23, 2023
1y Target Est N/A

6815.TWO Valuation Measures

Enterprise Value 2.69B TWD
Trailing P/E 56.41026
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.493517
Price/Book (mrq) 7.3510985
Enterprise Value/Revenue 5.003
Enterprise Value/EBITDA 29.741

Trading Information

Diamond Biotechnology Co., Ltd Stock Price History

Beta (5Y Monthly) 0.322341
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 150.57 TWD
52 Week Low 29.39 TWD
50-Day Moving Average 111.72 TWD
200-Day Moving Average 62.99 TWD

6815.TWO Share Statistics

Avg. Volume (3 month) 220.42K TWD
Avg. Daily Volume (10-Days) 105.12K TWD
Shares Outstanding 27.48M
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.122
Trailing Annual Dividend Yield 0.13%
5 Year Average Dividend Yield N/A
Payout Ratio 0.1024
Last Split Factor 1043:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) June 30, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 8.51%
Operating Margin (ttm) 12.02%
Gross Margin 42.98%
EBITDA Margin 16.82%

Management Effectiveness

Return on Assets (ttm) 6.10%
Return on Equity (ttm) 14.87%

Income Statement

Revenue (ttm) 538.25M TWD
Revenue Per Share (ttm) 19.58 TWD
Quarterly Revenue Growth (yoy) 53.60%
Gross Profit (ttm) 184.32M TWD
EBITDA 90.54M TWD
Net Income Avi to Common (ttm) 45.83M TWD
Diluted EPS (ttm) 1.56
Quarterly Earnings Growth (yoy) 71.70%

Balance Sheet

Total Cash (mrq) 64.19M TWD
Total Cash Per Share (mrq) 2.33 TWD
Total Debt (mrq) 335.29M TWD
Total Debt/Equity (mrq) 101.78 TWD
Current Ratio (mrq) 1.373
Book Value Per Share (mrq) 11.971

Cash Flow Statement

Operating Cash Flow (ttm) 138.46M TWD
Levered Free Cash Flow (ttm) -74224752 TWD

Profile of Diamond Biotechnology Co., Ltd

Country Taiwan
State N/A
City Taipei
Address No. 45, Fuxing South Road
ZIP N/A
Phone 886 2 2755 3320
Website https://www.diamond-biotechnology.cc
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees N/A

Diamond Biotechnology Co., Ltd researches, develops, manufactures, and sells medical equipment and skincare products in Taiwan and internationally. The company offers medical beauty-level skin care products under the Timera and Diamond Beauty brands. It also leases medical equipment. The company was founded in 2014 and is based in Taipei, Taiwan.

Q&A For Diamond Biotechnology Co., Ltd Stock

What is a current 6815.TWO stock price?

Diamond Biotechnology Co., Ltd 6815.TWO stock price today per share is 104.5 TWD.

How to purchase Diamond Biotechnology Co., Ltd stock?

You can buy 6815.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Diamond Biotechnology Co., Ltd?

The stock symbol or ticker of Diamond Biotechnology Co., Ltd is 6815.TWO.

Which industry does the Diamond Biotechnology Co., Ltd company belong to?

The Diamond Biotechnology Co., Ltd industry is Medical Devices.

How many shares does Diamond Biotechnology Co., Ltd have in circulation?

The max supply of Diamond Biotechnology Co., Ltd shares is 27.48M.

What is Diamond Biotechnology Co., Ltd Price to Earnings Ratio (PE Ratio)?

Diamond Biotechnology Co., Ltd PE Ratio is 66.56051000 now.

What was Diamond Biotechnology Co., Ltd earnings per share over the trailing 12 months (TTM)?

Diamond Biotechnology Co., Ltd EPS is 1.57 TWD over the trailing 12 months.

Which sector does the Diamond Biotechnology Co., Ltd company belong to?

The Diamond Biotechnology Co., Ltd sector is Healthcare.